ORGANOGENESIS HOLDINGS INC.
ORGO · NASDAQ
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
Market Data
Price
$2.35
+0.05 (+2.17%)
Market Cap$302M
P/E Ratio8.16
EPS$—
52W High$7.08
52W Low$2.21
Beta1.33
Data from Finnhub · Updated May 1, 2026